{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:52:40Z","timestamp":1789775560020,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0108124"],"award-info":[{"award-number":["JP18fk0108124"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K22644"],"award-info":[{"award-number":["19K22644"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20H03861"],"award-info":[{"award-number":["20H03861"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K08609"],"award-info":[{"award-number":["22K08609"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mitsui Sumitomo Insurance Welfare Foundation Research Grant 2021"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01345-0","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T04:43:24Z","timestamp":1766465004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal vaccination with probiotic Escherichia coli membrane vesicles displaying pneumococcal capsular polysaccharides elicits mucosal immunity"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-8518","authenticated-orcid":false,"given":"Ryoma","family":"Nakao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukino","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Narisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Akeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"1345_CR1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"Collaborators, G. B. D. A. R","year":"2022","unstructured":"Collaborators, G. B. D. A. R Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 2221\u20132248 (2022).","journal-title":"Lancet"},{"key":"1345_CR2","doi-asserted-by":"publisher","first-page":"S570","DOI":"10.1093\/infdis\/jiz053","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi, T. et al. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis. J. Infect. Dis. 222, S570\u2013S576 (2020).","journal-title":"J. Infect. Dis."},{"key":"1345_CR3","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/j.vaccine.2017.05.049","volume":"35","author":"JJ LeBlanc","year":"2017","unstructured":"LeBlanc, J. J. et al. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: a Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. Vaccine 35, 3647\u20133654 (2017).","journal-title":"Vaccine"},{"key":"1345_CR4","doi-asserted-by":"publisher","first-page":"e0244324","DOI":"10.1128\/spectrum.02443-24","volume":"13","author":"J Yu","year":"2025","unstructured":"Yu, J. et al. New pneumococcal serotype 20C is a WciG O-acetyltransferase deficient variant of canonical serotype 20B. Microbiol. Spectr. 13, e0244324 (2025).","journal-title":"Microbiol. Spectr."},{"key":"1345_CR5","doi-asserted-by":"publisher","unstructured":"Ganaie, F. et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus. mBio 11, https:\/\/doi.org\/10.1128\/mBio.00937-20 (2020).","DOI":"10.1128\/mBio.00937-20"},{"key":"1345_CR6","doi-asserted-by":"publisher","first-page":"e0002423","DOI":"10.1128\/jcm.00024-23","volume":"61","author":"FA Ganaie","year":"2023","unstructured":"Ganaie, F. A. et al. Discovery and characterization of pneumococcal serogroup 36 capsule subtypes, serotypes 36A and 36B. J. Clin. Microbiol. 61, e0002423 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"1345_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"Collaborators, G. B. D. L. R. I","year":"2018","unstructured":"Collaborators, G. B. D. L. R. I Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1191\u20131210 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1345_CR8","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1093\/infdis\/jiae040","volume":"230","author":"A Kalizang\u2019oma","year":"2024","unstructured":"Kalizang\u2019oma, A. et al. Clonal expansion of a Streptococcus pneumoniae serotype 3 capsule variant sequence type 700 with enhanced vaccine escape potential after 13-valent pneumococcal conjugate vaccine introduction. J. Infect. Dis. 230, e189\u2013e198 (2024).","journal-title":"J. Infect. Dis."},{"key":"1345_CR9","doi-asserted-by":"publisher","first-page":"126219","DOI":"10.1016\/j.vaccine.2024.126219","volume":"42","author":"C Candeias","year":"2024","unstructured":"Candeias, C. et al. Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: a cross-sectional study. Vaccine 42, 126219 (2024).","journal-title":"Vaccine"},{"key":"1345_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1473-3099(24)00742-4","volume":"25","author":"C von Mollendorf","year":"2025","unstructured":"von Mollendorf, C. & Ong-Lim, A. L. T. How have pneumococcal conjugate vaccines changed the pneumococcal disease landscape?. Lancet Infect. Dis. 25, 367\u2013369 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"1345_CR11","doi-asserted-by":"publisher","unstructured":"Ranjbar, R. & Alam, M. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Evid. Based Nurs. https:\/\/doi.org\/10.1136\/ebnurs-2022-103540 (2023).","DOI":"10.1136\/ebnurs-2022-103540"},{"key":"1345_CR12","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3201\/eid2910.230519","volume":"29","author":"C Hyams","year":"2023","unstructured":"Hyams, C. et al. Serotype distribution and disease severity in adults hospitalized with Streptococcus pneumoniae infection, Bristol and Bath, UK, 2006\u20122022. Emerg. Infect. Dis. 29, 1953\u20131964 (2023).","journal-title":"Emerg. Infect. Dis."},{"key":"1345_CR13","doi-asserted-by":"publisher","first-page":"127221","DOI":"10.1016\/j.micres.2022.127221","volume":"266","author":"L Li","year":"2023","unstructured":"Li, L. et al. Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review. Microbiol. Res. 266, 127221 (2023).","journal-title":"Microbiol. Res."},{"key":"1345_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","volume":"73","author":"M Kobayashi","year":"2024","unstructured":"Kobayashi, M. et al. Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2024. MMWR Morb. Mortal Wkly Rep. 73, 793\u2013798 (2024).","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"1345_CR15","doi-asserted-by":"publisher","unstructured":"Rappuoli, R. Glycoconjugate vaccines: principles and mechanisms. Sci. Transl. Med. 10, https:\/\/doi.org\/10.1126\/scitranslmed.aat4615 (2018).","DOI":"10.1126\/scitranslmed.aat4615"},{"key":"1345_CR16","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","volume":"7","author":"C Chen","year":"2019","unstructured":"Chen, C. et al. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob. Health 7, e58\u2013e67 (2019).","journal-title":"Lancet Glob. Health"},{"key":"1345_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1086\/423001","volume":"39","author":"RB Belshe","year":"2004","unstructured":"Belshe, R. B. et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5\u201349 years. Clin. Infect. Dis. 39, 920\u2013927 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"1345_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/infdis\/jiac433","volume":"227","author":"J Eiden","year":"2022","unstructured":"Eiden, J. et al. Intranasal M2SR (M2-deficient single replication) H3N2 influenza vaccine provides enhanced mucosal and serum antibodies in adults. J. Infect. Dis. 227, 103\u2013112 (2022).","journal-title":"J. Infect. Dis."},{"key":"1345_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/infdis\/jiae504","volume":"231","author":"TM Babu","year":"2025","unstructured":"Babu, T. M., Jackson, L. A. & El Sahly, H. M. Next-generation SARS-CoV-2 vaccine formulations and alternative routes of administration. J. Infect. Dis. 231, 44\u201348 (2025).","journal-title":"J. Infect. Dis."},{"key":"1345_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01096-y","volume":"10","author":"K Chu","year":"2025","unstructured":"Chu, K. et al. A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3\u201317 years. NPJ Vaccines 10, 50 (2025).","journal-title":"NPJ Vaccines"},{"key":"1345_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","volume":"10","author":"JX Li","year":"2022","unstructured":"Li, J. X. et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respir. Med. 10, 739\u2013748 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1345_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-1900-1_13","volume":"2414","author":"S Hirayama","year":"2022","unstructured":"Hirayama, S. & Nakao, R. Glycine induction method: effective production of immunoactive bacterial membrane vesicles with low endotoxin content. Methods Mol. Biol. 2414, 207\u2013226 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1345_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/1751-7915.13572","volume":"13","author":"S Hirayama","year":"2020","unstructured":"Hirayama, S. & Nakao, R. Glycine significantly enhances bacterial membrane vesicle production: a powerful approach for isolation of LPS-reduced membrane vesicles of probiotic Escherichia coli. Microb. Biotechnol. 13, 1162\u20131178 (2020).","journal-title":"Microb. Biotechnol."},{"key":"1345_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00572-z","volume":"7","author":"R Nakao","year":"2022","unstructured":"Nakao, R. et al. A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles. NPJ Vaccines 7, 153 (2022).","journal-title":"NPJ Vaccines"},{"key":"1345_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/649839","volume":"201","author":"DM Musher","year":"2010","unstructured":"Musher, D. M. et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J. Infect. Dis. 201, 516\u2013524 (2010).","journal-title":"J. Infect. Dis."},{"key":"1345_CR26","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/cid\/civ686","volume":"61","author":"CH van Werkhoven","year":"2015","unstructured":"van Werkhoven, C. H., Huijts, S. M., Bolkenbaas, M., Grobbee, D. E. & Bonten, M. J. The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly. Clin. Infect. Dis. 61, 1835\u20131838 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1345_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1128\/IAI.01275-15","volume":"84","author":"N Thevaranjan","year":"2016","unstructured":"Thevaranjan, N. et al. Streptococcus pneumoniae colonization disrupts the microbial community within the upper respiratory tract of aging mice. Infect. Immun. 84, 906\u2013916 (2016).","journal-title":"Infect. Immun."},{"key":"1345_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/CJI.0b013e31818f13c4","volume":"32","author":"R Cubas","year":"2009","unstructured":"Cubas, R. et al. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J. Immunother. 32, 118\u2013128 (2009).","journal-title":"J. Immunother."},{"key":"1345_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt1332","volume":"25","author":"ST Reddy","year":"2007","unstructured":"Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25, 1159\u20131164 (2007).","journal-title":"Nat. Biotechnol."},{"key":"1345_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1126\/science.aav9000","volume":"363","author":"JT Wilson","year":"2019","unstructured":"Wilson, J. T. A sweeter approach to vaccine design. Science 363, 584\u2013585 (2019).","journal-title":"Science"},{"key":"1345_CR31","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.xcrm.2022.100899","volume":"4","author":"N Munoz-Wolf","year":"2023","unstructured":"Munoz-Wolf, N. et al. Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles. Cell Rep. Med. 4, 100899 (2023).","journal-title":"Cell Rep. Med."},{"key":"1345_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41577-024-01073-x","volume":"25","author":"SE Degn","year":"2025","unstructured":"Degn, S. E. & Tolar, P. Towards a unifying model for B-cell receptor triggering. Nat. Rev. Immunol. 25, 77\u201391 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1345_CR33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.add8065","volume":"377","author":"P Tolar","year":"2022","unstructured":"Tolar, P. & Pierce, S. K. Unveiling the B cell receptor structure. Science 377, 819\u2013820 (2022).","journal-title":"Science"},{"key":"1345_CR34","doi-asserted-by":"publisher","unstructured":"Olivo-Martinez, Y. et al. Modulation of serotonin-related genes by extracellular vesicles of the probiotic Escherichia coli Nissle 1917 in the interleukin-1beta-induced inflammation model of intestinal epithelial cells. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25105338 (2024).","DOI":"10.3390\/ijms25105338"},{"key":"1345_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fmicb.2018.00498","volume":"9","author":"MA Canas","year":"2018","unstructured":"Canas, M. A., Fabrega, M. J., Gimenez, R., Badia, J. & Baldoma, L. Outer membrane vesicles from probiotic and commensal Escherichia coli activate NOD1-mediated immune responses in intestinal epithelial cells. Front. Microbiol. 9, 498 (2018).","journal-title":"Front. Microbiol."},{"key":"1345_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(21)01967-X","volume":"398","author":"S Jerving","year":"2021","unstructured":"Jerving, S. The long road ahead for COVID-19 vaccination in Africa. Lancet 398, 827\u2013828 (2021).","journal-title":"Lancet"},{"key":"1345_CR37","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/S0140-6736(21)00924-7","volume":"397","author":"ESL Loyo","year":"2021","unstructured":"Loyo, E. S. L., Gonzalez, M. J. & Esparza, J. Venezuela is collapsing without COVID-19 vaccines. Lancet 397, 1806 (2021).","journal-title":"Lancet"},{"key":"1345_CR38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0140-6736(20)32657-X","volume":"397","author":"X Li","year":"2021","unstructured":"Li, X. et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet 397, 398\u2013408 (2021).","journal-title":"Lancet"},{"key":"1345_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0092-8674(00)00071-4","volume":"102","author":"JR Zhang","year":"2000","unstructured":"Zhang, J. R. et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102, 827\u2013837 (2000).","journal-title":"Cell"},{"key":"1345_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/mdr.1997.3.401","volume":"3","author":"DE Briles","year":"1997","unstructured":"Briles, D. E. et al. PspA and PspC: their potential for use as pneumococcal vaccines. Microb. Drug Resist. 3, 401\u2013408 (1997).","journal-title":"Microb. Drug Resist."},{"key":"1345_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1365-2958.1997.5391899.x","volume":"25","author":"S Hammerschmidt","year":"1997","unstructured":"Hammerschmidt, S., Talay, S. R., Brandtzaeg, P. & Chhatwal, G. S. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25, 1113\u20131124 (1997).","journal-title":"Mol. Microbiol."},{"key":"1345_CR42","doi-asserted-by":"publisher","first-page":"48178","DOI":"10.1074\/jbc.M306906200","volume":"278","author":"L Lu","year":"2003","unstructured":"Lu, L., Lamm, M. E., Li, H., Corthesy, B. & Zhang, J. R. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J. Biol. Chem. 278, 48178\u201348187 (2003).","journal-title":"J. Biol. Chem."},{"key":"1345_CR43","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1172\/JCI84705","volume":"126","author":"F Iovino","year":"2016","unstructured":"Iovino, F. et al. Pneumococcal meningitis is promoted by single cocci expressing pilus adhesin RrgA. J. Clin. Investig. 126, 2821\u20132826 (2016).","journal-title":"J. Clin. Investig."},{"key":"1345_CR44","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1084\/jem.20161668","volume":"214","author":"F Iovino","year":"2017","unstructured":"Iovino, F. et al. pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion. J. Exp. Med. 214, 1619\u20131630 (2017).","journal-title":"J. Exp. Med."},{"key":"1345_CR45","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","volume":"173","author":"KB Renegar","year":"2004","unstructured":"Renegar, K. B., Small, P. A. Jr, Boykins, L. G. & Wright, P. F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173, 1978\u20131986 (2004).","journal-title":"J. Immunol."},{"key":"1345_CR46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4049\/jimmunol.160.3.1219","volume":"160","author":"KB Renegar","year":"1998","unstructured":"Renegar, K. B., Jackson, G. D. & Mestecky, J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J. Immunol. 160, 1219\u20131223 (1998).","journal-title":"J. Immunol."},{"key":"1345_CR47","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.1503885112","volume":"112","author":"T Suzuki","year":"2015","unstructured":"Suzuki, T. et al. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus. Proc. Natl. Acad. Sci. USA 112, 7809\u20137814 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1345_CR48","doi-asserted-by":"publisher","first-page":"e1007427","DOI":"10.1371\/journal.ppat.1007427","volume":"15","author":"S Saito","year":"2019","unstructured":"Saito, S. et al. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody. PLoS Pathog. 15, e1007427 (2019).","journal-title":"PLoS Pathog."},{"key":"1345_CR49","doi-asserted-by":"publisher","first-page":"e01792","DOI":"10.1128\/mBio.01792-15","volume":"7","author":"LE Keller","year":"2016","unstructured":"Keller, L. E., Robinson, D. A. & McDaniel, L. S. Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis. mBio 7, e01792 (2016).","journal-title":"mBio"},{"key":"1345_CR50","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1055\/s-0028-1135392","volume":"42","author":"A Nissle","year":"1916","unstructured":"Nissle, A. \u00dcber die Grundlagen einer neuen urs\u00e4chlichen Bek\u00e4mpfung der pathologischen Darmflora. Dtsch. Med. Wochenschr. 42, 1181\u20131184 (1916).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"1345_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-1119(91)90366-J","volume":"100","author":"RF Wang","year":"1991","unstructured":"Wang, R. F. & Kushner, S. R. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100, 195\u2013199 (1991).","journal-title":"Gene"},{"key":"1345_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep24931","volume":"6","author":"NL Price","year":"2016","unstructured":"Price, N. L. et al. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci. Rep. 6, 24931 (2016).","journal-title":"Sci. Rep."},{"key":"1345_CR53","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1128\/JCM.01937-09","volume":"48","author":"M Imohl","year":"2010","unstructured":"Imohl, M., Reinert, R. R., Ocklenburg, C. & van der Linden, M. Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. J. Clin. Microbiol. 48, 1291\u20131296 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"1345_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"1345_CR55","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"1345_CR56","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","volume":"168","author":"Y Asahi","year":"2002","unstructured":"Asahi, Y. et al. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168, 2930\u20132938 (2002).","journal-title":"J. Immunol."},{"key":"1345_CR57","first-page":"379","volume":"11","author":"M Abdus Salam","year":"2004","unstructured":"Abdus Salam, M. et al. Establishment of an animal model using recombinant NOD.B10.D2 mice to study initial adhesion of oral streptococci. Clin. Diagn. Lab. Immunol. 11, 379\u2013386 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"1345_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1538\/expanim.60.481","volume":"60","author":"S Kawai","year":"2011","unstructured":"Kawai, S., Takagi, Y., Kaneko, S. & Kurosawa, T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp. Anim. 60, 481\u2013487 (2011).","journal-title":"Exp. Anim."},{"key":"1345_CR59","doi-asserted-by":"publisher","unstructured":"Bai, D., Nakao, R., Ito, A., Uematsu, H. & Senpuku, H. Immunoreactive antigens recognized in serum samples from mice intranasally immunized with Porphyromonas gingivalis outer membrane vesicles. Pathog. Dis. 73, https:\/\/doi.org\/10.1093\/femspd\/ftu006 (2015).","DOI":"10.1093\/femspd\/ftu006"},{"key":"1345_CR60","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","volume":"25","author":"I Henckaerts","year":"2007","unstructured":"Henckaerts, I., Durant, N., De Grave, D., Schuerman, L. & Poolman, J. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine 25, 2518\u20132527 (2007).","journal-title":"Vaccine"},{"key":"1345_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","volume":"13","author":"S Romero-Steiner","year":"2006","unstructured":"Romero-Steiner, S. et al. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin. Vaccine Immunol. 13, 165\u2013169 (2006).","journal-title":"Clin. Vaccine Immunol."},{"key":"1345_CR62","first-page":"616","volume":"10","author":"KH Kim","year":"2003","unstructured":"Kim, K. H., Yu, J. & Nahm, M. H. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10, 616\u2013621 (2003).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"1345_CR63","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/CVI.00112-06","volume":"13","author":"RL Burton","year":"2006","unstructured":"Burton, R. L. & Nahm, M. H. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin. Vaccine Immunol. 13, 1004\u20131009 (2006).","journal-title":"Clin. Vaccine Immunol."},{"key":"1345_CR64","unstructured":"Nahm, M. H. & Burton, R. L. Protocol for multiplexed opsonophagocytic killing assay (UAB-MOPA) for antibodies against Streptococcus pneumoniae Protoc. UAB-MOPA 1\u201343 Version E.02, https:\/\/www.vaccine.uab.edu\/index.html (2014)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01345-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01345-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:03:34Z","timestamp":1769184214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01345-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01345-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}